Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When oxcarbazepine patent expired?When will latisse patent expire?Campath litigation germany?Guselkumab loss of exclusitivy?Guselkumab patent expiration?
See the DrugPatentWatch profile for cosentyx
What does Cosentyx list as side effects? Cosentyx lists upper respiratory infections, diarrhea, and nasal congestion as common side effects. It does not list appetite suppression among them. Does Cosentyx affect appetite at all? No clinical data or prescribing information shows Cosentyx causing appetite changes or weight loss. The drug's mechanism as an IL-17A inhibitor does not target pathways linked to appetite regulation. What happens if someone reports appetite loss on Cosentyx? Patients experiencing appetite loss while taking Cosentyx should report it to their doctor. The symptom could stem from other causes such as infection, concurrent medications, or an unrelated condition. How does Cosentyx compare with other biologics on this issue? Most IL-17 inhibitors and TNF inhibitors do not list appetite suppression as a side effect. Some patients report weight changes with TNF inhibitors, but these reports remain rare and unlinked to a direct mechanism. When does Cosentyx lose exclusivity? Cosentyx exclusivity ends in 2027, with biosimilar versions entering the market in 2028.
Other Questions About Cosentyx :